Sampson, J. H., Vlahovic, G., Sahebjam, S., Omuro, A. M. P., Baehring, J. M., Hafler, D. A., … Reardon, D. A. (2015). Preliminary safety and activity of nivolumab and its combination with ipilimumab in recurrent glioblastoma (GBM): CHECKMATE-143. In Journal of Clinical Oncology (Vol. 33, pp. 3010–3010). American Society of Clinical Oncology (ASCO). https://doi.org/10.1200/jco.2015.33.15_suppl.3010

Sampson, John H., Gordana Vlahovic, Solmaz Sahebjam, Antonio Marcilio Padula Omuro, Joachim M. Baehring, David A. Hafler, Alfredo Daniel Voloschin, et al. “Preliminary safety and activity of nivolumab and its combination with ipilimumab in recurrent glioblastoma (GBM): CHECKMATE-143.” In Journal of Clinical Oncology, 33:3010–3010. American Society of Clinical Oncology (ASCO), 2015. https://doi.org/10.1200/jco.2015.33.15_suppl.3010.

Sampson JH, Vlahovic G, Sahebjam S, Omuro AMP, Baehring JM, Hafler DA, et al. Preliminary safety and activity of nivolumab and its combination with ipilimumab in recurrent glioblastoma (GBM): CHECKMATE-143. In: Journal of Clinical Oncology. American Society of Clinical Oncology (ASCO); 2015. p. 3010–3010.

Sampson, John H., et al. “Preliminary safety and activity of nivolumab and its combination with ipilimumab in recurrent glioblastoma (GBM): CHECKMATE-143.” Journal of Clinical Oncology, vol. 33, no. 15_suppl, American Society of Clinical Oncology (ASCO), 2015, pp. 3010–3010. Crossref, doi:10.1200/jco.2015.33.15_suppl.3010.

Sampson JH, Vlahovic G, Sahebjam S, Omuro AMP, Baehring JM, Hafler DA, Voloschin AD, Paliwal P, Grosso J, Coric V, Cloughesy TF, Lim M, Reardon DA. Preliminary safety and activity of nivolumab and its combination with ipilimumab in recurrent glioblastoma (GBM): CHECKMATE-143. Journal of Clinical Oncology. American Society of Clinical Oncology (ASCO); 2015. p. 3010–3010.